UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Journal of biopharmaceutical statistics, 2021-11, Vol.31 (6), p.723-735

Snapinn, Steven

2021

Link zum Volltext

Verfügbarkeit prüfen

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator

The American statistician, 2005-11, Vol.59 (4), p.301-307

2005

Link zum Volltext

Verfügbarkeit prüfen

Alternatives for Discounting in the Analysis of Noninferiority Trials

Journal of biopharmaceutical statistics, 2004-12, Vol.14 (2), p.263-273

Snapinn, Steven M.

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Sample Size Requirements of Randomized and Historically Controlled Trials Based on Calibrated Error Rates

Statistics in biopharmaceutical research, 2023-01, Vol.15 (1), p.69-73

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group": The Test Statistic Should Estimate Some Reasonable Measure of Treatment Benefit

Statistics in biopharmaceutical research, 2023-04, Vol.15 (2), p.297-299

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on "The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations"

Statistics in biopharmaceutical research, 2021-02, Vol.13 (1), p.40-42

2021

Link zum Volltext

Verfügbarkeit prüfen

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Journal of biopharmaceutical statistics, 2013-07, Vol.23 (4), p.719-729

2013

Link zum Volltext

Verfügbarkeit prüfen

Separate Modeling Approaches for Survival Analysis with Inaccurate Covariate Measurements

Journal of biopharmaceutical statistics, 2004-12, Vol.14 (2), p.375-387

2004

Link zum Volltext

Verfügbarkeit prüfen

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

Statistics in biopharmaceutical research, 2014-10, Vol.6 (4), p.349-355

2014

Link zum Volltext

Verfügbarkeit prüfen

On Errors in Stratified Randomization

Statistics in biopharmaceutical research, 2017-04, Vol.9 (2), p.225-233

2017

Link zum Volltext

Verfügbarkeit prüfen

Nonproportional Hazards and the Power of Sequential Trials

Statistics in biopharmaceutical research, 2009-02, Vol.1 (1), p.66-73

2009

Link zum Volltext

Verfügbarkeit prüfen

Responder Analyses-A PhRMA Position Paper

Statistics in biopharmaceutical research, 2011-08, Vol.3 (3), p.476-487

2011

Link zum Volltext

Verfügbarkeit prüfen

Uncertainty in Clinical Endpoints: Information and Retrieval

Statistics in biopharmaceutical research, 2009-11, Vol.1 (4), p.362-365

2009

Link zum Volltext

Verfügbarkeit prüfen

PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial

Statistics in biopharmaceutical research, 2010-11, Vol.2 (4), p.522-531

2010

Link zum Volltext

Verfügbarkeit prüfen

Snapinn, S. M., Jiang, Q., and Iglewicz, B. (2005), "Illustrating the Impact of a Time-Varying Covariate with an Extended Kaplan-Meier Estimator," "The American Statistician", 59, 301-307: Comment by Beyersmann, Gerds, and Schumacher and Response

The American statistician, 2006-08, Vol.60 (3), p.295-296

2006

Link zum Volltext

Verfügbarkeit prüfen

Response

Statistics in biopharmaceutical research, 2010-11, Vol.2 (4), p.538-539

2010

Link zum Volltext

Verfügbarkeit prüfen

Response

Statistics in biopharmaceutical research, 2010-11, Vol.2 (4), p.538-539

2010

Link zum Volltext

Verfügbarkeit prüfen

Use of the randomization distribution in the analysis of sequential clinical trials

Communications in statistics. Theory and methods, 1994-01, Vol.23 (2), p.485-498

Snapinn, Steven M.

1994

Link zum Volltext

Verfügbarkeit prüfen

A note on assessing the superiority of a combination drug with a specific alternative

Journal of biopharmaceutical statistics, 1996, Vol.6 (3), p.241-251

1996

Link zum Volltext

Verfügbarkeit prüfen

An Evaluation of Smoothed Classification Error - Rate Estimators

Technometrics, 1985-05, Vol.27 (2), p.199-206

1985

Link zum Volltext

Verfügbarkeit prüfen

An Evaluation of Smoothed Classification Error - Rate Estimators

Technometrics, 1985-05, Vol.27 (2), p.199

1985

Link zum Volltext

Verfügbarkeit prüfen

Classification Error Rate Estimators Evaluated by Unconditional Mean Squared Error

Technometrics, 1984-11, Vol.26 (4), p.371-378

1984

Link zum Volltext

Verfügbarkeit prüfen

Bootstrapped and smoothed classification error rate estimators

Communications in statistics. Simulation and computation, 1988-01, Vol.17 (4), p.1135-1153

1988

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator

Alternatives for Discounting in the Analysis of Noninferiority Trials

Comparison of Sample Size Requirements of Randomized and Historically Controlled Trials Based on Calibrated Error Rates

Comment on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group": The Test Statistic Should Estimate Some Reasonable Measure of Treatment Benefit

Comment on "The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations"

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Separate Modeling Approaches for Survival Analysis with Inaccurate Covariate Measurements

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

On Errors in Stratified Randomization

Nonproportional Hazards and the Power of Sequential Trials

Responder Analyses-A PhRMA Position Paper

Uncertainty in Clinical Endpoints: Information and Retrieval

PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial

Snapinn, S. M., Jiang, Q., and Iglewicz, B. (2005), "Illustrating the Impact of a Time-Varying Covariate with an Extended Kaplan-Meier Estimator," "The American Statistician", 59, 301-307: Comment by Beyersmann, Gerds, and Schumacher and Response

Response

Response

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the losartan inventervention for endpoint reduction in hypertension study

Use of the randomization distribution in the analysis of sequential clinical trials

A note on assessing the superiority of a combination drug with a specific alternative

An Evaluation of Smoothed Classification Error - Rate Estimators

An Evaluation of Smoothed Classification Error - Rate Estimators

Classification Error Rate Estimators Evaluated by Unconditional Mean Squared Error

Bootstrapped and smoothed classification error rate estimators

Aktive Filter

Suchergebnisse filtern